TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Interest Expenses (2022 - 2026)

Updated

TScan Therapeutics (TCRX) posted Interest Expenses of $775,000 for Q3 2026, up 10.9% from $699,000 a year earlier and up 10.9% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Interest Expenses (2022 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Interest Expenses at TScan Therapeutics was $2.87 million, up 0.5% year-over-year; for FY2025, it came in at $2.77 million, down 24.2% from FY2024.

  • Annual Interest Expenses shows a three-year compound annual growth rate of 33.0% (FY2022 to FY2025).
  • In prior years, TScan Therapeutics' Interest Expenses was $3.65 million in FY2024 (-2.8%), $3.76 million in FY2023 (+219.6%) and $1.18 million in FY2022.
  • The Q3 2026 figure stands as the highest quarterly Interest Expenses since Q4 2024.
  • On a year-over-year basis, Interest Expenses has increased in each of the last three quarters, with an average decline of 11.1% over the last eight quarters.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q3 2023, with growth of 388.6%; the weakest was Q1 2025, with a decline of 29.2%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $699,000 (Q2 2026), $689,000 (Q1 2026) and $702,000 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -15,526.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 217.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 269.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 775,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 775,000.00
Jun 30, 2026 699,000.00
Mar 31, 2026 689,000.00
Dec 31, 2025 702,000.00
Sep 30, 2025 699,000.00
Jun 30, 2025 689,000.00
Mar 31, 2025 679,000.00
Dec 31, 2024 784,000.00
Sep 30, 2024 958,000.00
Jun 30, 2024 952,000.00
Mar 31, 2024 959,000.00
Dec 31, 2023 852,000.00
Sep 30, 2023 982,000.00
Jun 30, 2023 969,000.00
Mar 31, 2023 956,000.00
Dec 31, 2022 975,000.00
Sep 30, 2022 201,000.00
API Access

TScan Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=TCRX&period=max&api_key=YOUR_API_KEY